HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adenocarcinoma of the lung with selective metastasis to the lung: clinical, histologic and DNA-cytofluorometric analyses.

Abstract
In order to examine selective lung metastasis in lung adenocarcinoma, 7 patients who had died due to metastasis exclusively to the lung were analyzed. Because all of the tumors had been well differentiated adenocarcinoma, 21 cases of well differentiated adenocarcinoma which had metastasized to both the lung and other distant organs were selected as controls. Histologically, 6 of the 7 study cases were bronchiolo-alveolar carcinoma (BAC) of variable cytological type or papillary adenocarcinoma with a thin fibrovascular stroma without apparent destruction of the alveolar wall. There was no difference in clinical findings or nuclear DNA content (NDC) between the BAC and papillary adenocarcinoma with thin fibrovascular stroma. The fibrovascular stroma in the study cases was significantly thinner than that in the control cases (P less than 0.01). Cytofluorometrically, the study cases had a significantly lower and less abnormal NDC than the control cases in terms of the mean NDC and DNA histogram patterns (P less than 0.01 and P less than 0.05, respectively). On the basis of these findings, we conclude that 1) BAC can be classified within the same spectrum as well differentiated papillary adenocarcinoma, and 2) selective lung metastasis occurs in well differentiated adenocarcinomas showing mild NDC abnormalities and having a thin fibrovascular stroma without apparent destruction of the alveolar wall.
AuthorsH Nomori, Y Matsuno, M Noguchi, S Tsugane, Y Shimosato, S Hirohashi
JournalJapanese journal of cancer research : Gann (Jpn J Cancer Res) Vol. 83 Issue 1 Pg. 93-100 (Jan 1992) ISSN: 0910-5050 [Print] Japan
PMID1544877 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA
Topics
  • Adenocarcinoma (metabolism, secondary, therapy)
  • Aged
  • Cell Nucleus (metabolism)
  • DNA (metabolism)
  • Female
  • Flow Cytometry
  • Humans
  • Lung Neoplasms (metabolism, secondary, therapy)
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: